Contamination of blood by HIV in France: facts, controversies and impact on society. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Contamination of blood by HIV in France: facts, controversies and impact on society.

Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:19 (abstract no. TPI-3). Unique Identifier : AIDSLINE ASHM5/94348935
Brunet JB; European Centre for the Epidemiology Monitoring of AIDS,; Saint-Maurice, France.

Abstract: Screening of blood donors has been mandatory in France since 1st August 1985. Virus inactivated Factor VIII concentrates were progressively introduced for treatment of haemophiliacs and by 1st October 1985 all non-heated products had been replaced. By 30th June 1993, 1223 AIDS cases linked to blood transfusions and 323 cases among haemophiliacs had been reported. These figures are disproportionally higher than those observed in comparable European countries for the former group and similar or lower for the latter. Trials ongoing since 1988 have led to prison sentences for the director of the National Centre for Blood Transfusion and one medical expert. Administrative courts have considered the State responsible for all HIV infection acquired through transfusion and a 1992 law has created a specific compensation mechanism for an estimated total cost of 2 billion $US. Court decisions on similar cases concerning hepatitis transmission are now pending. A global legislation for the development of a national insurance system for medical hazards is being considered by the French parliament.
Keywords: Blood Transfusion/*LEGISLATION & JURISPRUD *Blood-Borne Pathogens Comparative Study Cross-Cultural Comparison Cross-Sectional Studies France/EPIDEMIOLOGY Human HIV Infections/EPIDEMIOLOGY/PREVENTION & CONTROL/*TRANSMISSION Incidence ABSTRACTKWDbloodtransfusion/KWDlegislation&jurisprudKWDblood-bornepathogenscomparativestudycross-culturalcomparisoncross-sectionalstudiesfrance/epidemiologyhumanhivinfections/epidemiology/prevention&control/KWDtransmissionincidenceabstract
941230
M94C4292

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .